A Study of ARRY-438162 (MEK162) in Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Metastatic Colorectal Cancer
Related studies linked through entity extraction aliases.
Safety and Efficacy Study of Panitumumab+Irinotecan in Patients Wild-Type (WT) KRAS Metastatic Colorectal Cancer Refractory to Irinotecan Based Chemotherapy (SPECTRA)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Capecitabine and Cetuximab as First-Line Therapy in Patients With Metastatic Wild Type Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase I and Pharmacokinetic Study of Biweekly PEP02 in mCRC Refractory to 1st-line Oxaliplatin Base Therapy
- Status
- COMPLETED
- Phase
- PHASE1
CY-503 for the Treatment of Chemotherapy-refractory Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib
- Status
- COMPLETED
- Phase
- PHASE1
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
- Status
- COMPLETED
- Phase
- PHASE3
Study About Preventive Treatment of Folliculitis Induced by Epidermal Growth Factor Receptor Inhibitors
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate Mechanisms of Acquired Resistance to Panitumumab
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Safety, Tolerability and Efficacy of FOLFOX + CT-011 Versus FOLFOX Alone
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan, Capecitabine and Bevacizumab in Metastatic Colorectal Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Dulanermin Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of Modified FOLFOX6 Plus or Minus Sorafenib in Stage IV Metastatic Colorectal Carcinoma (mCRC) Subjects
- Status
- COMPLETED
- Phase
- PHASE2
Post-First Progression Use of Bevacizumab in Metastatic Colorectal Cancer (mCRC)
- Status
- COMPLETED
- Phase
- PHASE2
Biomarker - Panitumumab Response With KRAS Wild Type MCC
- Status
- COMPLETED
- Phase
- NA
Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of PRO95780 Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, and Metastatic Colorectal Cancer (APM4566g)
- Status
- COMPLETED
- Phase
- PHASE1
Study of Chemoembolisation Using Irinotecan Bead Prior to Surgery in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of IMC-11F8 in Participants With Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2